Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 27 June 1986:
Vol. 232. no. 4758, pp. 1629 - 1632
DOI: 10.1126/science.3487117

Articles

Science, Vol 232, Issue 4758, 1629-1632
Copyright © 1986 by American Association for the Advancement of Science


articles

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

M Brownlee, H Vlassara, A Kooney, P Ulrich, and A Cerami

Age-associated increases in collagen cross-linking and accumulation of advanced glycosylation products are both accelerated by diabetes, suggesting that glucose-derived cross-link formation may contribute to the development of chronic diabetic complications as well as certain physical changes of aging. Aminoguanidine, a nucleophilic hydrazine compound, prevented both the formation of fluorescent advanced nonenzymatic glycosylation products and the formation of glucose-derived collagen cross-links in vitro. Aminoguanidine administration to rats was equally effective in preventing diabetes-induced formation of fluorescent advanced nonenzymatic glycosylation products and cross-linking of arterial wall connective tissue protein in vivo. The identification of aminoguanidine as an inhibitor of advanced nonenzymatic glycosylation product formation now makes possible precise experimental definition of the pathogenetic significance of this process and suggests a potential clinical role for aminoguanidine in the future treatment of chronic diabetic complications.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Novel Sartan Derivative With Very Low Angiotensin II Type 1 Receptor Affinity Protects the Kidney in Type 2 Diabetic Rats.
Y. Izuhara, T. Sada, H. Yanagisawa, H. Koike, S. Ohtomo, T. Dan, S. Ito, M. Nangaku, C. van Ypersele de Strihou, and T. Miyata (2008)
Arterioscler. Thromb. Vasc. Biol. 28, 1767-1773
   Abstract »    Full Text »    PDF »
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes.
S.-Y. Goh and M. E. Cooper (2008)
J. Clin. Endocrinol. Metab. 93, 1143-1152
   Abstract »    Full Text »    PDF »
A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor.
S. M. Grundy (2008)
Eur. Heart J. Suppl. 10, B16-B23
   Abstract »    Full Text »    PDF »
A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models.
Y. Izuhara, M. Nangaku, S. Takizawa, S. Takahashi, J. Shao, H. Oishi, H. Kobayashi, C. van Ypersele de Strihou, and T. Miyata (2008)
Nephrol. Dial. Transplant. 23, 497-509
   Abstract »    Full Text »    PDF »
Evidence for in Vivo Scavenging by Aminoguanidine of Formaldehyde Produced via Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination.
M. Kazachkov, K. Chen, S. Babiy, and P. H. Yu (2007)
J. Pharmacol. Exp. Ther. 322, 1201-1207
   Abstract »    Full Text »    PDF »
Association between glycosylated hemoglobin, left ventricular mass and aortic function in nondiabetic individuals with insulin resistance.
D. A Stakos, D. P Schuster, E. A Sparks, S. B. Meis, C. F Wooley, K. Osei, and H. Boudoulas (2007)
Eur. J. Endocrinol. 157, 63-68
   Abstract »    Full Text »    PDF »
Methylglyoxal Inhibits the Binding Step of Collagen Phagocytosis.
S. A. C. Chong, W. Lee, P. D. Arora, C. Laschinger, E. W. K. Young, C. A. Simmons, M. Manolson, J. Sodek, and C. A. McCulloch (2007)
J. Biol. Chem. 282, 8510-8520
   Abstract »    Full Text »    PDF »
Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy?.
M. T. Coughlan, V. Thallas-Bonke, J. Pete, D. M. Long, A. Gasser, D. C. K. Tong, M. Arnstein, S. R. Thorpe, M. E. Cooper, and J. M. Forbes (2007)
Endocrinology 148, 886-895
   Abstract »    Full Text »    PDF »
Diabetes and Advanced Glycoxidation End Products..
A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch (2006)
Diabetes Care 29, 1420-1432
   Full Text »    PDF »
Advanced Glycation End Products Inhibit Tubulogenesis and Migration of Kidney Epithelial Cells in an Ezrin-Dependent Manner.
M. A Gallicchio, E. A. McRobert, A. Tikoo, M. E. Cooper, and L. A. Bach (2006)
J. Am. Soc. Nephrol. 17, 414-421
   Abstract »    Full Text »    PDF »
Advanced glycation end products and the kidney.
J. M. Bohlender, S. Franke, G. Stein, and G. Wolf (2005)
Am J Physiol Renal Physiol 289, F645-F659
   Abstract »    Full Text »    PDF »
Glucosepane Is a Major Protein Cross-link of the Senescent Human Extracellular Matrix: RELATIONSHIP WITH DIABETES.
D. R. Sell, K. M. Biemel, O. Reihl, M. O. Lederer, C. M. Strauch, and V. M. Monnier (2005)
J. Biol. Chem. 280, 12310-12315
   Abstract »    Full Text »    PDF »
Aminoguanidine Prevents Fructose-Induced Arterial Stiffening in Wistar Rats: Aortic Impedance Analysis.
Y.-T. Lin, Y.-Z. Tseng, and K.-C. Chang (2004)
Experimental Biology and Medicine 229, 1038-1045
   Abstract »    Full Text »    PDF »
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.
G. Basta, A. M. Schmidt, and R. De Caterina (2004)
Cardiovasc Res 63, 582-592
   Abstract »    Full Text »    PDF »
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis.
J. M. Forbes, L. T. L. Yee, V. Thallas, M. Lassila, R. Candido, K. A. Jandeleit-Dahm, M. C. Thomas, W. C. Burns, E. K. Deemer, S. R. Thorpe, et al. (2004)
Diabetes 53, 1813-1823
   Abstract »    Full Text »    PDF »
Diabetic Retinopathy.
R. N. Frank (2004)
N. Engl. J. Med. 350, 48-58
   Full Text »    PDF »
Modification of Proteins In Vitro by Physiological Levels of Glucose: PYRIDOXAMINE INHIBITS CONVERSION OF AMADORI INTERMEDIATE TO ADVANCED GLYCATION END-PRODUCTS THROUGH BINDING OF REDOX METAL IONS.
P. A. Voziyan, R. G. Khalifah, C. Thibaudeau, A. Yildiz, J. Jacob, A. S. Serianni, and B. G. Hudson (2003)
J. Biol. Chem. 278, 46616-46624
   Abstract »    Full Text »    PDF »
The Amino-terminal Domains of the Ezrin, Radixin, and Moesin (ERM) Proteins Bind Advanced Glycation End Products, an Interaction That May Play a Role in the Development of Diabetic Complications.
E. A. McRobert, M. Gallicchio, G. Jerums, M. E. Cooper, and L. A. Bach (2003)
J. Biol. Chem. 278, 25783-25789
   Abstract »    Full Text »    PDF »
Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy.
K. L. Herrmann, A. D. McCulloch, and J. H. Omens (2003)
Am J Physiol Heart Circ Physiol 284, H1277-H1284
   Abstract »    Full Text »    PDF »
Collagen cross-linking: new dimension to cardiac remodeling.
S. K.G Koshy, H. K Reddy, and H. H Shukla (2003)
Cardiovasc Res 57, 594-598
   Full Text »    PDF »
Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats.
D. Badenhorst, M. Maseko, O. J Tsotetsi, A. Naidoo, R. Brooksbank, G. R Norton, and A. J Woodiwiss (2003)
Cardiovasc Res 57, 632-641
   Abstract »    Full Text »    PDF »
Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies.
Z. He, C. Rask-Madsen, and G.L. King (2003)
Eur. Heart J. Suppl. 5, B51-B57
   Abstract »    PDF »
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications.
M. J. Sheetz and G. L. King (2002)
JAMA 288, 2579-2588
   Abstract »    Full Text »    PDF »
Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy.
H. Vlassara, W. Cai, J. Crandall, T. Goldberg, R. Oberstein, V. Dardaine, M. Peppa, and E. J. Rayfield (2002)
PNAS 99, 15596-15601
   Abstract »    Full Text »    PDF »
Glycation by Ascorbic Acid Causes Loss of Activity of Ribulose-1,5-Bisphosphate Carboxylase/Oxygenase and Its Increased Susceptibility to Proteases.
Y. Yamauchi, Y. Ejiri, and K. Tanaka (2002)
Plant Cell Physiol. 43, 1334-1341
   Abstract »    Full Text »    PDF »
Reduction of the Accumulation of Advanced Glycation End Products by ACE Inhibition in Experimental Diabetic Nephropathy.
J. M. Forbes, M. E. Cooper, V. Thallas, W. C. Burns, M. C. Thomas, G. C. Brammar, F. Lee, S. L. Grant, L. A. Burrell, G. Jerums, et al. (2002)
Diabetes 51, 3274-3282
   Abstract »    Full Text »    PDF »
Angiotensin II Receptor Antagonists and Angiotensin-Converting Enzyme Inhibitors Lower In Vitro the Formation of Advanced Glycation End Products: Biochemical Mechanisms.
T. Miyata, C. van Ypersele de Strihou, Y. Ueda, K. Ichimori, R. Inagi, H. Onogi, N. Ishikawa, M. Nangaku, and K. Kurokawa (2002)
J. Am. Soc. Nephrol. 13, 2478-2487
   Abstract »    Full Text »    PDF »
Peroxynitrite Induces Formation of N{varepsilon}-(Carboxymethyl)Lysine by the Cleavage of Amadori Product and Generation of Glucosone and Glyoxal From Glucose: Novel Pathways for Protein Modification by Peroxynitrite.
R. Nagai, Y. Unno, M. C. Hayashi, S. Masuda, F. Hayase, N. Kinae, and S. Horiuchi (2002)
Diabetes 51, 2833-2839
   Abstract »    Full Text »    PDF »
Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
K. Yamamoto, T. Masuyama, Y. Sakata, N. Nishikawa, T. Mano, J. Yoshida, T. Miwa, M. Sugawara, Y. Yamaguchi, T. Ookawara, et al. (2002)
Cardiovasc Res 55, 76-82
   Abstract »    Full Text »    PDF »
A Post-Amadori Inhibitor Pyridoxamine Also Inhibits Chemical Modification of Proteins by Scavenging Carbonyl Intermediates of Carbohydrate and Lipid Degradation.
P. A. Voziyan, T. O. Metz, J. W. Baynes, and B. G. Hudson (2002)
J. Biol. Chem. 277, 3397-3403
   Abstract »    Full Text »    PDF »
Aminoguanidine and Aortic Wall Mechanics, Structure, and Composition in Aged Rats.
C. Cantini, P. Kieffer, B. Corman, P. Liminana, J. Atkinson, and I. Lartaud-Idjouadiene (2001)
Hypertension 38, 943-948
   Abstract »    Full Text »    PDF »
Effect of Chronic Aminoguanidine Treatment on Age-Related Glycation, Glycoxidation, and Collagen Cross-linking in the Fischer 344 Rat.
D. R. Sell, J. F. Nelson, and V. M. Monnier (2001)
J. Gerontol. A Biol. Sci. Med. Sci. 56, B405-411
   Abstract »    Full Text »    PDF »
Glucose and Palmitic Acid Induce Degeneration of Myofibrils and Modulate Apoptosis in Rat Adult Cardiomyocytes.
D. Dyntar, M. Eppenberger-Eberhardt, K. Maedler, M. Pruschy, H. M. Eppenberger, G. A. Spinas, and M. Y. Donath (2001)
Diabetes 50, 2105-2113
   Abstract »    Full Text »    PDF »
Abnormalities of Retinal Metabolism in Diabetes and Experimental Galactosemia: VII. Effect of Long-Term Administration of Antioxidants on the Development of Retinopathy.
R. A. Kowluru, J. Tang, and T. S. Kern (2001)
Diabetes 50, 1938-1942
   Abstract »    Full Text »    PDF »
The Diabetic Foot : Basic Mechanisms of Disease.
G. P. Guyton and C. L. Saltzman (2001)
J. Bone Joint Surg. Am. 83, 1083-1096
   Full Text »
Pharmacological Inhibition of Diabetic Retinopathy: Aminoguanidine and Aspirin.
T. S. Kern and R. L. Engerman (2001)
Diabetes 50, 1636-1642
   Abstract »    Full Text »    PDF »
Advanced glycation: an important pathological event in diabetic and age related ocular disease.
A. W STITT (2001)
Br. J. Ophthalmol. 85, 746-753
   Full Text »    PDF »
Reduction in Myocardial Collagen Cross-Linking Parallels Left Ventricular Dilatation in Rat Models of Systolic Chamber Dysfunction.
A. J. Woodiwiss, O. J. Tsotetsi, S. Sprott, E. J. Lancaster, T. Mela, E. S. Chung, T. E. Meyer, and G. R. Norton (2001)
Circulation 103, 155-160
   Abstract »    Full Text »    PDF »
Mechanism of the Inhibitory Effect of OPB-9195 [({+/-})-2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide] on Advanced Glycation End Product and Advanced Lipoxidation End Product Formation.
T. MIYATA, Y. UEDA, K. ASAHI, Y. IZUHARA, R. INAGI, A. SAITO, C. VAN YPERSELE DE STRIHOU, and K. KUROKAWA (2000)
J. Am. Soc. Nephrol. 11, 1719-1725
   Abstract »    Full Text »
Advanced Glycation and Lipoxidation End Products: Role of Reactive Carbonyl Compounds Generated during Carbohydrate and Lipid Metabolism.
T. MIYATA, K. KUROKAWA, and C. VAN YPERSELE DE STRIHOU (2000)
J. Am. Soc. Nephrol. 11, 1744-1752
   Full Text »
Food Restriction Prevents Advanced Glycation End Product Accumulation and Retards Kidney Aging in Lean Rats.
L. TEILLET, P. VERBEKE, S. GOURAUD, H. BAKALA, C. BOROT-LALOI, D. HEUDES, P. BRUNEVAL, and B. CORMAN (2000)
J. Am. Soc. Nephrol. 11, 1488-1497
   Abstract »    Full Text »
Molecular basis for a link between complement and the vascular complications of diabetes.
J. Acosta, J. Hettinga, R. Fluckiger, N. Krumrei, A. Goldfine, L. Angarita, and J. Halperin (2000)
PNAS 97, 5450-5455
   Abstract »    Full Text »    PDF »
Treatment of Diabetic Retinopathy.
F. L. Ferris, M. D. Davis, and L. M. Aiello (1999)
N. Engl. J. Med. 341, 667-678
   Full Text »    PDF »
Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.
A. H. Neufeld, A. Sawada, and B. Becker (1999)
PNAS 96, 9944-9948
   Abstract »    Full Text »    PDF »
Immunohistochemical Evidence for an Increased Oxidative Stress and Carbonyl Modification of Proteins in Diabetic Glomerular Lesions.
D. SUZUKI, T. MIYATA, N. SAOTOME, K. HORIE, R. INAGI, Y. YASUDA, K. UCHIDA, Y. IZUHARA, M. YAGAME, H. SAKAI, et al. (1999)
J. Am. Soc. Nephrol. 10, 822-832
   Abstract »    Full Text »
Age-Induced Protein Modifications and Increased Proteolysis in Potato Seed-Tubers.
G.N. M. Kumar, R. L. Houtz, and N. R. Knowles (1999)
Plant Physiology 119, 89-100
   Abstract »    Full Text »
Metabolic Delivery of Ketone Groups to Sialic Acid Residues. APPLICATION TO CELL SURFACE GLYCOFORM ENGINEERING.
K. J. Yarema, L. K. Mahal, R. E. Bruehl, E. C. Rodriguez, and C. R. Bertozzi (1998)
J. Biol. Chem. 273, 31168-31179
   Abstract »    Full Text »    PDF »
Influence of Glycation on LDL-Induced Generation of Fibrinolytic Regulators in Vascular Endothelial Cells.
J. Zhang, S. Ren, D. Sun, and G. X. Shen (1998)
Arterioscler. Thromb. Vasc. Biol. 18, 1140-1148
   Abstract »    Full Text »    PDF »
Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products.
X. Wang, R. Bucala, and R. Milne (1998)
PNAS 95, 7643-7647
   Abstract »    Full Text »    PDF »
Breakers of advanced glycation end products restore large artery properties in experimental diabetes.
B. H. R. Wolffenbuttel, C. M. Boulanger, F. R. L. Crijns, M. S. P. Huijberts, P. Poitevin, G. N. M. Swennen, S. Vasan, J. J. Egan, P. Ulrich, A. Cerami, et al. (1998)
PNAS 95, 4630-4634
   Abstract »    Full Text »    PDF »
AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.
A. Bierhaus, M. A Hofmann, R. Ziegler, and P. P Nawroth (1998)
Cardiovasc Res 37, 586-600
   Abstract »    Full Text »    PDF »
Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy.
B. Corman, M. Duriez, P. Poitevin, D. Heudes, P. Bruneval, A. Tedgui, and B. I. Levy (1998)
PNAS 95, 1301-1306
   Abstract »    Full Text »    PDF »
Effects of Metformin on Collagen Glycation and Diastolic Dysfunction in Diabetic Myocardium.
G.N. Jyothirmayi, B.J. Soni, M. Masurekar, M. Lyons, and T.J. Regan (1998)
Journal of Cardiovascular Pharmacology and Therapeutics 3, 319-326
   Abstract »    PDF »
TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms.
N. K. Worrall, K. Chang, W. S. Lejeune, T. P. Misko, P. M. Sullivan, T. B. Ferguson Jr., and J. R. Williamson (1997)
Am J Physiol Heart Circ Physiol 273, H2565-H2574
   Abstract »    Full Text »    PDF »
Myocardial Stiffness Is Attributed to Alterations in Cross-Linked Collagen Rather Than Total Collagen or Phenotypes in Spontaneously Hypertensive Rats.
G. R. Norton, J. Tsotetsi, B. Trifunovic, C. Hartford, G. P. Candy, and A. J. Woodiwiss (1997)
Circulation 96, 1991-1998
   Abstract »    Full Text »
Inhibitory Effects of Tenilsetam on the Maillard Reaction.
H. Shoda, S. Miyata, B.-F. Liu, H. Yamada, T. Ohara, K. Suzuki, M. Oimomi, and M. Kasuga (1997)
Endocrinology 138, 1886-1892
   Abstract »    Full Text »    PDF »
In Vitro Kinetic Studies of Formation of Antigenic Advanced Glycation End Products (AGEs). NOVEL INHIBITION OF POST-AMADORI GLYCATION PATHWAYS.
A. A. Booth, R. G. Khalifah, P. Todd, and B. G. Hudson (1997)
J. Biol. Chem. 272, 5430-5437
   Abstract »    Full Text »    PDF »
Long Term Effects of Aminoguanidine on Insulin Release and Biosynthesis: Evidence That the Formation of Advanced Glycosylation End Products Inhibits B Cell Function.
Y. Tajiri, C. Moller, and V. Grill (1997)
Endocrinology 138, 273-280
   Abstract »    Full Text »    PDF »
Inhibition of Inducible Nitric Oxide Synthase Attenuates Established Acute Cardiac Allograft Rejection.
N. K. Worrall, T. P. Misko, P. M. Sullivan, J.-J. Hui, and T. B. Ferguson Jr (1996)
Ann. Thorac. Surg. 62, 378-385
   Abstract »    Full Text »
Involvement of Hydrogen Peroxide in Collagen Cross-linking by High Glucose in Vitro and in Vivo.
A. Elgawish, M. Glomb, M. Friedlander, and V. M. Monnier (1996)
J. Biol. Chem. 271, 12964-12971
   Abstract »    Full Text »    PDF »
Aminoguanidine Prevents the Decreased Myocardial Compliance Produced by Streptozotocin-Induced Diabetes Mellitus in Rats.
G. R. Norton, G. Candy, and A. J. Woodiwiss (1996)
Circulation 93, 1905-1912
   Abstract »    Full Text »
Inhibition of Inducible Nitric Oxide Synthase Prevents Myocardial and Systemic Vascular Barrier Dysfunction During Early Cardiac Allograft Rejection.
N. K. Worrall, K. Chang, G. M. Suau, W. S. Allison, T. P. Misko, P. M. Sullivan, R. G. Tilton, J. R. Williamson, and T. B. Ferguson Jr (1996)
Circ. Res. 78, 769-779
   Abstract »    Full Text »
The Advanced Glycation End Product, N[IMAGE]-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions.
M.-X. Fu, J.ús R. Requena, A. J. Jenkins, T. J. Lyons, J. W. Baynes, and S. R. Thorpe (1996)
J. Biol. Chem. 271, 9982-9986
   Abstract »    Full Text »    PDF »
Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction.
M. A. Glomb and V. M. Monnier (1995)
J. Biol. Chem. 270, 10017-10026
   Abstract »    Full Text »    PDF »
Aminoguanidine Has Both Pro-oxidant and Antioxidant Activity Toward LDL.
A. Philis-Tsimikas, S. Parthasarathy, S. Picard, W. Palinski, and J. L. Witztum (1995)
Arterioscler. Thromb. Vasc. Biol. 15, 367-376
   Abstract »    Full Text »
Matrix Nonenzymatic Glycosylation Leads to Altered Cellular Phenotype and Intracellular Tyrosine Phosphorylation.
G. Hasegawa, A. J. Hunter, and A. S. Charonis (1995)
J. Biol. Chem. 270, 3278-3283
   Abstract »    Full Text »    PDF »
Novel Degradation Pathway of Glycated Amino Acids into Free Fructosamine by a Pseudomonas sp. Soil Strain Extract.
C. Gerhardinger, M. S. Marion, A. Rovner, M. Glomb, and V. M. Monnier (1995)
J. Biol. Chem. 270, 218-224
   Abstract »    Full Text »    PDF »
Hemoglobin-AGE: a circulating marker of advanced glycosylation.
Z Makita, H Vlassara, E Rayfield, K Cartwright, E Friedman, R Rodby, A Cerami, and R Bucala (1992)
Science 258, 651-653
   Abstract »    PDF »
Chelating Activity of Advanced Glycation End-product Inhibitors.
D. L. Price, P. M. Rhett, S. R. Thorpe, and J. W. Baynes (2001)
J. Biol. Chem. 276, 48967-48972
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)